A study published in the Psychological Medicine journal emphasised a lesser-known effect of major depressive disorder: it may ...

A new study published in Psychological Medicine has found that individuals with major depressive disorder have brains that ...

But people who have a major depressive episode have higher levels of translocator proteins. Those are chemicals linked to brain inflammation. Studies show these proteins are even higher in people ...

Austin psychiatrist Dr. Donald J. Garcia is enrolling patients in a study on a new kind of medication for major depressive ...

A study published in the journal Psychological Medicine has identified major depressive disorder’s contribution to increasing brain age, showing how people with depression may have brains that appear ...

A new study published in the American Journal of Psychiatry sheds light on how psilocybin and the antidepressant escitalopram ...

A mechanism involving potassium channels in the brain that control brain cell activity could provide a new and fundamentally different way of treating depression symptoms in adults with major ...

Learn the common symptoms of depression, from persistent sadness to physical changes, and understand when to seek ...

Exploration of extending ketamine’s antidepressant effects by enhancing intracellular signaling pathways in major depressive ...

The phase III X-TOLE2 and X-TOLE3 trials in focal-onset seizures are ongoing, with the first topline data readout anticipated ...

Researchers at Mount Sinai found that ezogabine, a drug activating KCNQ potassium channels, helps reduce depressive symptoms and anhedonia by modulating brain activity. Functional MRI showed the drug ...

The FDA cleared “Deep TMS,” which uses a different kind of coil to reach deeper brain structures, to treat major depressive disorder in 2013 and OCD in 2018. Focused ultrasound has been ...